Neogen Chemicals Limited has released its Q2 FY27 Earnings Presentation, detailing its financial performance and outlining key expansion initiatives. The presentation covers unaudited financial results for the quarter and half-year ended September 30, 2026. Key highlights include revenue growth, EBITDA performance, and strategic advancements in its battery chemicals business, particularly through Neogen Ionics.
Neogen Chemicals Unveils Q2 FY27 Performance and Growth Strategies
Neogen Chemicals Limited has officially published its Q2 FY27 Earnings Presentation, providing a comprehensive overview of its financial results for the quarter and half-year ending September 30, 2026. The document details both standalone and consolidated financial performance, alongside significant expansion initiatives underway across the company.
Financial Highlights for Q2 FY27
The presentation showcases notable financial achievements. Revenues saw a 39% increase on a standalone basis, reaching INR 288 crore, and a 42% increase consolidated, amounting to INR 296 crore. Gross Profit also demonstrated strong growth, with a 27% rise standalone (INR 121 crore) and a 36% rise consolidated (INR 133 crore). EBITDA performance was robust, up 54% standalone to INR 54 crore and 51% consolidated to INR 45 crore. Profit After Tax (PAT) saw significant surges of 127% standalone (INR 21 crore) and 144% consolidated (INR 8 crore).
The revenue break-up indicates a strong domestic contribution at 66%, with exports accounting for 34%. Organic business led revenue at 80%, compared to 20% from inorganic business. Consolidated figures also highlight the accelerated scaling in the Battery Chemicals division, with Neogen Ionics (NIL) contributing INR 37 crore in Q2 FY27, a substantial increase from INR 5.4 crore in Q2 FY26.
Key Expansion Initiatives and Updates
Neogen Chemicals is actively pursuing significant expansion. The board has approved the expansion of the Organolithium facility at Patancheru, Telangana, doubling its capacity from 300 MTPA to 600 MTPA with an estimated investment of INR 45 crore. This expansion is expected to generate additional revenue potential of INR 150 to INR 200 crore based on lithium prices.
In its Battery Chemicals business, Neogen Ionics is progressing with its proposed manufacturing setup. Plans include expanding electrolyte capacity to 32,000 MT and Lithium Electrolyte Salts & Additives to 5,500 MT by FY27. The company is also nearing completion of key projects, with mechanical completion timelines on schedule for Electrolytes and Electrolyte Salts.
The company also reported on its insurance claim status, with cumulative recoveries standing at INR 164 crore to date. Furthermore, Neogen successfully raised INR 600 crore via its maiden QIP issue, which was oversubscribed by 6.5x, attracting strong participation from institutional investors. The proceeds are earmarked for debt repayment and funding incremental business requirements.
Strategic Outlook and Future Focus
The management commentary emphasizes a robust all-round performance despite challenging macroeconomic conditions. The company is focused on transitioning its Battery Chemicals business from capital investment to execution and ramp-up. Neogen Chemicals aims to leverage its R&D expertise to introduce innovative offerings, expand capabilities in adjacent high-end complex chemistries, and deepen its inroads into the Battery Materials segment. The company is committed to driving sustainable growth through ESG excellence, focusing on clean energy, robust oversight, ethical foundations, and strengthening corporate governance.
Source: BSE
